Naturally Splendid COVID-19 PHASE II Clinical Trial

 

Naturally Splendid
  • Naturally Splendid CavaltinibTM for Covid-19, Phase II Clinical Trial Health Canada Application status update.
  • Medical product CavaltinibTM so far is showing that it is a prospective contender for COVID-19 treatment, and possibly additional immune system and inflammatory conditions.
  • Health Canada’s Office of Regulatory Affairs’ Biologic and Radiopharmaceutical Drugs Directorate approval is next for the CavaltinibTMafter the application passed initial review from Health Canada.
  • The fast-track initiative for Coronavirus research, resulting in Phase II Clinical trials, will include COVID-19 applications, and applications for any other possible positive respiratory results discovered from the trials.

Naturally Splendid Enterprises (NSE), in conjuntion with Biologic Pharmamedical Research has successfully entered into Phase II Clinical Trials for CavaltinibTM; a contender as a possible Covid-19 Novel Coronavirus treatment. Working co-operatively to support Biologic, Naturally Splendid collaberates plans to conduct Phase II clinical studies in Canada and the USA for Covid-19 as per NSE’s May 19th press releaese. By passing Health Canada application review for CavaltinibTM for Covid-19 together Naturally Splendid and Biologic have now been fast tracked for Covid-19 Cornavirus reseach, as well as other respiratory applications.

Medical product CavaltinibTM so far is showing that it is a prospective competitor for COVID-19 treatment, and possibly additional immune system and inflammatory conditions. Phase II Clinical Trial Health Canada Application status update full details in the full article in the below link.

See Full Article

About Naturally Splendid Enterprises Ltd.

NSE operates a Safe Quality Food Level 2 certified food manufacturing facility just outside Vancouver, BC in Canada. We have established numerous healthy, functional foods under recognized brands such as Natera Sport(TM), Natera Hemp Foods, CHII (TM), Elevate Me(TM) and Woods Wild Bar. The Company has a myriad of new products and line extensions under development that are approaching launch. NSE has also developed proprietary technologies for the extraction of high demand, healthy omega 3 and 6 oils from hemp. (NSE sales revenues for the first half 2019 exceeded FY2018).NSE is the current “go-to” manufacturer for healthy, functional food products and ingredients focusing on plant-based ingredients. The Company provides contract manufacturing services for many global healthy food companies, private labelling a wide variety of nutritional food products destined for global healthy food markets.

Previous Related News Release – May 19, 2020

You Tube Interview – May 21, 2020

Get paid to make an impact on stocks.


All posts made on this website are provided for information purposes only. None of the information here is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. Before making an investment decision, you should seek the advice of a qualified and registered securities professional. Candlr is not receiving payment or commissions from companies for shared content on Candlr website unless its specified. View full disclaimer HERE.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.